VANGUARD GROUP INC - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 257 filers reported holding KARUNA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$541,694,188
-19.4%
3,203,585
+3.4%
0.01%
-18.8%
Q2 2023$671,779,399
+22.5%
3,097,899
+2.6%
0.02%
+14.3%
Q1 2023$548,470,335
+1.4%
3,019,546
+9.7%
0.01%
-6.7%
Q4 2022$541,071,199
-8.2%
2,753,543
+5.0%
0.02%
-11.8%
Q3 2022$589,672,000
+114.5%
2,621,585
+20.7%
0.02%
+112.5%
Q2 2022$274,870,000
+2.2%
2,172,714
+2.4%
0.01%
+33.3%
Q1 2022$268,940,000
-1.5%
2,121,152
+1.8%
0.01%0.0%
Q4 2021$273,048,000
+8.1%
2,084,336
+0.9%
0.01%0.0%
Q3 2021$252,659,000
+10.0%
2,065,391
+2.5%
0.01%0.0%
Q2 2021$229,775,000
+0.1%
2,015,750
+5.6%
0.01%0.0%
Q1 2021$229,543,000
+85.4%
1,909,203
+56.7%
0.01%
+50.0%
Q4 2020$123,798,000
+34.2%
1,218,601
+2.2%
0.00%
+33.3%
Q3 2020$92,225,000
-24.1%
1,192,754
+9.4%
0.00%
-25.0%
Q2 2020$121,553,000
+235.3%
1,090,552
+116.6%
0.00%
+100.0%
Q1 2020$36,251,000
+11.9%
503,467
+17.1%
0.00%
+100.0%
Q4 2019$32,393,000
+794.6%
429,954
+93.8%
0.00%
Q3 2019$3,621,000
+179.8%
221,880
+243.4%
0.00%
Q2 2019$1,294,00064,6120.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders